News About: Pharm. Affairs
Pharmaceutical companies are careful to introduce ‘Viagra for women’ in the domestic market
When it comes to introduction of ‘Addvi(flibanserine)’, a FDA-approved female hyposexuality treatment, domestic pharmaceutical companies have been careful, meaning that more verification in its effectiveness and marke...
Will counterattack of ‘injection’ in diabetes treatment make any chance in recognition?
Although the largest treatment in diabetes patients to control blood sugar is known to be ‘injection,’ its usage is relatively small in Korea compared to other foreign countries.
This is because of the fact that pati...
The leading DPP-4 inhibitor market worth of KRW 260 billion has been fueled again
The DPP-4 inhibitor-type diabetes treatment market has been fueled again.
Although 6 products have been competing in the market, Handok, which has shown its capacity in the diabetes market, also, entered the market a...
Emergence of the ‘first-titled’ domestic vaccines attracted the depressed domestic market
2 vaccines, titled as the ‘first’ in the domestic market, appeared.
One of them is GSK’s ‘Fluarix Tetra,’ a tetravalent flu vaccine called as the next-generation vaccine. A number of tetravalent vaccines have been la...
Tenelia targets the top Januvia by effectiveness comparison
Movements of ‘Tenelia(generic name: teneligliptin),’ a DPP-4 inhibitor launched for the 7th time in the domestic market, have been aggressive. Handok has stressed its goal to name the drug in the ‘Top 3’ by showing it...
The 3 reasons why Cialis generics may struggle
Although 150 generic products of 50 pharmaceutical companies will be poured out facing the patent expiration of ‘Cialis(generic name: tadalafil) on September, the ‘spring of impotency treatment,’ happened in 2012, wil...
Will the two biosimilars sold by foreign companies be successful in the domestic market?
Lilly and MSD are expected to introduce biosimilars in the domestic market.
According to the industry concerned on the 18th, Lilly and MSD have turned in approval applications for biosimilars of ‘Lantus(insulin glarg...
The first domestic patent nullity of Humira will stimulate biosimilar development
One of domestic patents of Humira(Abbvie), a TNF-Alpha inhibitor used mainly in rheumatoid arthritis treatment, has been ruled to be nullified.
Thus, biosimilar development of domestic pharmaceutical companies, such ...
A half of doctor have had no idea if drug price decreases after patent expiration
A survey has shown that the most effective way to prevent ‘Patent Cliff,’ a phenomenon of decreasing sales of original products after generic launches, may be just ‘to inform the expiration to the public.’ Generally, ...
‘Toujeo,’ next-generation basal insulin, has been approved, competing against ‘Tresiba’
A number of next-generation long-acting basal insulin, which decreased risks in hypoglycemia occurrence, is about to enter the domestic market.
According to the industry concerned on the 14th, Sanofi-Aventis’s next-g...
